title: Endogenous Streptococcus agalactiae (Group B Streptococcus) endophthalmitis as a presenting sign of precursor T-cell lymphoblastic leukemia.
authors.forename: Seema R
authors.initials: SR
authors.lastname: Gupta
authors.forename: Shivali
authors.initials: S
authors.lastname: Agnani
authors.forename: Shandiz
authors.initials: S
authors.lastname: Tehrani
authors.forename: Steven
authors.initials: S
authors.lastname: Yeh
authors.forename: Andreas K
authors.initials: AK
authors.lastname: Lauer
authors.forename: Eric B
authors.initials: EB
authors.lastname: Suhler
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D009877:Endophthalmitis / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D015818:Eye Infections, Bacterial / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D054218:Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000628:therapy; D013290:Streptococcal Infections / Q000175:diagnosis / Q000382:microbiology* / Q000628:therapy; D013292:Streptococcus agalactiae / Q000302:isolation & purification*; D014821:Vitrectomy
chemical_list: D000900:Anti-Bacterial Agents